Clinical Trial Update: A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).

View source ↗

Summary

This retrospective study evaluates the toxicity and outcomes of high-dose chemotherapy with autologous stem cell transplant in patients with Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Hodgkin Lymphoma | Status: COMPLETED